Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 2004  
Type : Journal
Web link : http://www.ajhp.org/cgi/content/abstract/62/13/1381
Research teams : King of Prussia - SmithKline Beecham Pharmaceuticals
Authors : Patel K, Hursting MJ.
Title : Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
Reference : Am J Health-Syst Pharm ; 62: 1381-1384. 2005
Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 
List of drugs
injectionArgatroban Anticoagulant
Compatible 1 mg/ml + injectionEptifibatide 2 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 1 mg/ml + injectionTirofiban 50 µg/ml + NaCl 0,9% or Glucose 5%
injectionEptifibatide Anticoagulant
Compatible 2 mg/ml + injectionArgatroban 1 mg/ml + NaCl 0,9% or Glucose 5%
injectionTirofiban Anticoagulant
Compatible 50 µg/ml + injectionArgatroban 1 mg/ml + NaCl 0,9% or Glucose 5%
Stability of mixtures
Not specified NaCl 0,9% or Glucose 5% 20°C-25°C Not specified
injection Argatroban 0,5 mg/ml
injection Eptifibatide 1 mg/ml
4 Hour
Not specified NaCl 0,9% or Glucose 5% 20°C-25°C Not specified
injection Argatroban 0,9 mg/ml
injection Eptifibatide 0,1 mg/ml
4 Hour
Not specified NaCl 0,9% or Glucose 5% 20°C-25°C Not specified
injection Tirofiban 25 µg/ml
injection Argatroban 0,5 mg/ml
4 Hour
Not specified NaCl 0,9% or Glucose 5% 20°C-25°C Not specified
injection Tirofiban 5,5 µg/ml
injection Argatroban 0,85 mg/ml
4 Hour
  Mentions Légales